News & Media
EU antitrust authorities launch probe of Teva over Copaxone drug | The Times of Israel
Teva Pharmaceutical High Resolution Stock Photography and Images - Alamy
Teva Pharmaceutical CEO Shlomo Yanai delivers a press conference in Cologne, Germany, 18 March 2010. German generics producer Ratiopharm is sold to world's leading generic producer Teva Pharmaceutical at 3.625 billion euro.
The ALS Association, Huntington's Disease Society of America, and Teva Pharmaceuticals Launch Teva CNS Target Identification Challenge | The ALS Association
Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva Pharmaceutical Industries Limited (TEVA) - Faruqi & Faruqi LLP
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
New branded drugs helping Teva Pharm move closer to growth | Reuters
Teva Pharmaceuticals - Wikipedia
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Transitioning Teva revamps branding to emphasize brand-generic unity | Fierce Pharma
Teva Reports Third Quarter 2021 Financial Results
Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
News & Media
Teva Reports First Quarter 2020 Financial Results | Business Wire
Teva Pharmaceutical High Resolution Stock Photography and Images - Alamy
Global Biosimilar Hormones Market 2021, Industry Trends,
Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva enters opioid settlement agreement with US state Rhode Island
Teva Pharmaceuticals Acquisition – PL Developments
Jury holds drugmaker Teva liable in opioid crisis | WLUK
Teva shed 37% of Israel workforce in two years - Globes
